3SBio Inc.

SEHK:1530 Stock Report

Market Cap: HK$80.8b

3SBio Past Earnings Performance

Past criteria checks 5/6

3SBio has been growing earnings at an average annual rate of 13.4%, while the Biotechs industry saw earnings growing at 48.4% annually. Revenues have been growing at an average rate of 11.3% per year. 3SBio's return on equity is 13.2%, and it has net margins of 26%.

Key information

13.40%

Earnings growth rate

14.55%

EPS growth rate

Biotechs Industry Growth11.00%
Revenue growth rate11.31%
Return on equity13.19%
Net Margin25.99%
Last Earnings Update30 Jun 2025

Recent past performance updates

Solid Earnings Reflect 3SBio's (HKG:1530) Strength As A Business

May 07
Solid Earnings Reflect 3SBio's (HKG:1530) Strength As A Business

Recent updates

3SBio Inc.'s (HKG:1530) Shares Climb 28% But Its Business Is Yet to Catch Up

Nov 13
3SBio Inc.'s (HKG:1530) Shares Climb 28% But Its Business Is Yet to Catch Up

Analysts Just Shipped A Substantial Upgrade To Their 3SBio Inc. (HKG:1530) Estimates

Sep 03
Analysts Just Shipped A Substantial Upgrade To Their 3SBio Inc. (HKG:1530) Estimates

Estimating The Fair Value Of 3SBio Inc. (HKG:1530)

Sep 01
Estimating The Fair Value Of 3SBio Inc. (HKG:1530)

Should You Be Adding 3SBio (HKG:1530) To Your Watchlist Today?

Aug 15
Should You Be Adding 3SBio (HKG:1530) To Your Watchlist Today?

There's Reason For Concern Over 3SBio Inc.'s (HKG:1530) Massive 26% Price Jump

Jun 30
There's Reason For Concern Over 3SBio Inc.'s (HKG:1530) Massive 26% Price Jump

The Compensation For 3SBio Inc.'s (HKG:1530) CEO Looks Deserved And Here's Why

Jun 18
The Compensation For 3SBio Inc.'s (HKG:1530) CEO Looks Deserved And Here's Why

Analysts Just Published A Bright New Outlook For 3SBio Inc.'s (HKG:1530)

May 26
Analysts Just Published A Bright New Outlook For 3SBio Inc.'s (HKG:1530)

Are Investors Undervaluing 3SBio Inc. (HKG:1530) By 42%?

May 21
Are Investors Undervaluing 3SBio Inc. (HKG:1530) By 42%?

Solid Earnings Reflect 3SBio's (HKG:1530) Strength As A Business

May 07
Solid Earnings Reflect 3SBio's (HKG:1530) Strength As A Business

3SBio Inc. (HKG:1530) Stock Rockets 36% As Investors Are Less Pessimistic Than Expected

Apr 24
3SBio Inc. (HKG:1530) Stock Rockets 36% As Investors Are Less Pessimistic Than Expected

3SBio (HKG:1530) Has Announced A Dividend Of CN¥0.25

Apr 17
3SBio (HKG:1530) Has Announced A Dividend Of CN¥0.25

3SBio (HKG:1530) Will Pay A Dividend Of CN¥0.25

Mar 31
3SBio (HKG:1530) Will Pay A Dividend Of CN¥0.25

3SBio Inc. (HKG:1530) Released Earnings Last Week And Analysts Lifted Their Price Target To HK$10.80

Mar 30
3SBio Inc. (HKG:1530) Released Earnings Last Week And Analysts Lifted Their Price Target To HK$10.80

3SBio Inc. (HKG:1530) Soars 27% But It's A Story Of Risk Vs Reward

Mar 10
3SBio Inc. (HKG:1530) Soars 27% But It's A Story Of Risk Vs Reward

3SBio Inc. (HKG:1530) Screens Well But There Might Be A Catch

Jan 17
3SBio Inc. (HKG:1530) Screens Well But There Might Be A Catch

Revenue & Expenses Breakdown

How 3SBio makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SEHK:1530 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 259,0742,3593,9571,398
31 Mar 259,0912,2243,9051,362
31 Dec 249,1082,0903,8531,327
30 Sep 248,7651,8743,7731,145
30 Jun 248,4221,6593,693964
31 Mar 248,1191,6043,590880
31 Dec 237,8161,5493,487795
30 Sep 237,6861,7393,351750
30 Jun 237,5551,9293,215706
31 Mar 237,2101,9233,094700
31 Dec 226,8661,9162,974694
30 Sep 226,6181,8172,849699
30 Jun 226,3691,7192,725703
31 Mar 226,3761,6852,710729
31 Dec 216,3821,6512,696754
30 Sep 216,1911,3422,688717
30 Jun 216,0001,0322,681681
31 Mar 215,7949342,577636
31 Dec 205,5888362,472590
30 Sep 205,4791,0952,535581
30 Jun 205,3701,3552,598571
31 Mar 205,3441,1642,612549
31 Dec 195,3189742,627527
30 Sep 195,1851,0292,409549
30 Jun 195,0531,0842,190572
31 Mar 194,8181,1812,099468
31 Dec 184,5841,2772,008363
30 Sep 184,3931,1671,911181
30 Jun 184,2021,0571,8140
31 Mar 183,9689961,7310
31 Dec 173,7349351,6480
30 Sep 173,4678771,6010
30 Jun 173,1998181,5550
31 Mar 172,9987661,4370
31 Dec 162,7977131,3180
30 Sep 162,4926421,1040
30 Jun 162,1885718890
31 Mar 161,9305488000
31 Dec 151,6735267100
30 Sep 151,5034566760
30 Jun 151,3643417440
31 Mar 151,2473166730
31 Dec 141,1312926020

Quality Earnings: 1530 has high quality earnings.

Growing Profit Margin: 1530's current net profit margins (26%) are higher than last year (19.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 1530's earnings have grown by 13.4% per year over the past 5 years.

Accelerating Growth: 1530's earnings growth over the past year (42.2%) exceeds its 5-year average (13.4% per year).

Earnings vs Industry: 1530 earnings growth over the past year (42.2%) exceeded the Biotechs industry -4.1%.

Return on Equity

High ROE: 1530's Return on Equity (13.2%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/14 17:40
End of Day Share Price 2025/11/14 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

3SBio Inc. is covered by 35 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo YuChina International Capital Corporation Limited
Zhuhong ChenChina Merchants Securities (HK) Co., Ltd
Fangqi DaiChina Merchants Securities (HK) Co., Ltd